DrMelanie Föcking

Dr Föcking’s research has contributed to advancing understanding of the biological mechanisms underlying schizophrenia, particularly in relation to immune and inflammatory pathways. Her work in proteomics and biomarker discovery has supported efforts to identify objective biological signatures of psychotic disorders, with potential relevance for early diagnosis and precision psychiatry.

She has contributed to the development of international research collaborations in neuropsychiatry and has helped shape research directions in the field of molecular psychiatry through multi-centre and interdisciplinary projects.